These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23583259)

  • 1. Agonism of human pregnane X receptor by rilpivirine and etravirine: comparison with first generation non-nucleoside reverse transcriptase inhibitors.
    Sharma D; Lau AJ; Sherman MA; Chang TK
    Biochem Pharmacol; 2013 Jun; 85(11):1700-11. PubMed ID: 23583259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of human constitutive androstane receptor and its SV23 and SV24 splice variants by rilpivirine and etravirine.
    Sharma D; Lau AJ; Sherman MA; Chang TK
    Br J Pharmacol; 2015 Mar; 172(5):1263-76. PubMed ID: 25363652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of meclizine on the activity of human pregnane X receptor and constitutive androstane receptor.
    Lau AJ; Yang G; Rajaraman G; Baucom CC; Chang TK
    J Pharmacol Exp Ther; 2011 Mar; 336(3):816-26. PubMed ID: 21131266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective agonism of human pregnane X receptor by individual ginkgolides.
    Lau AJ; Yang G; Yap CW; Chang TK
    Drug Metab Dispos; 2012 Jun; 40(6):1113-21. PubMed ID: 22393123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etravirine and rilpivirine: nonnucleoside reverse transcriptase inhibitors with activity against human immunodeficiency virus type 1 strains resistant to previous nonnucleoside agents.
    Fulco PP; McNicholl IR
    Pharmacotherapy; 2009 Mar; 29(3):281-94. PubMed ID: 19249947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Archived HIV-1 DNA resistance mutations to rilpivirine and etravirine in successfully treated HIV-1-infected individuals pre-exposed to efavirenz or nevirapine.
    Gallien S; Charreau I; Nere ML; Mahjoub N; Simon F; de Castro N; Aboulker JP; Molina JM; Delaugerre C
    J Antimicrob Chemother; 2015 Feb; 70(2):562-5. PubMed ID: 25344807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pregnane X receptor agonism by Ginkgo biloba extract: assessment of the role of individual ginkgolides.
    Lau AJ; Yang G; Rajaraman G; Baucom CC; Chang TK
    J Pharmacol Exp Ther; 2010 Dec; 335(3):771-80. PubMed ID: 20739453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative Regulation of Human Pregnane X Receptor by MicroRNA-18a-5p: Evidence for Suppression of MicroRNA-18a-5p Expression by Rifampin and Rilpivirine.
    Sharma D; Turkistani AA; Chang W; Hu C; Xu Z; Chang TKH
    Mol Pharmacol; 2017 Jul; 92(1):48-56. PubMed ID: 28408657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors.
    Ghosn J; Chaix ML; Delaugerre C
    AIDS Rev; 2009; 11(3):165-73. PubMed ID: 19654858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the K101E substitution in HIV-1 reverse transcriptase in resistance to rilpivirine and other nonnucleoside reverse transcriptase inhibitors.
    Xu HT; Colby-Germinario SP; Huang W; Oliveira M; Han Y; Quan Y; Petropoulos CJ; Wainberg MA
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5649-57. PubMed ID: 24002090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver toxicity in HIV-infected patients receiving novel second-generation nonnucleoside reverse transcriptase inhibitors etravirine and rilpivirine.
    Casado JL
    AIDS Rev; 2013; 15(3):139-45. PubMed ID: 24002197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction between etravirine or rilpivirine and telaprevir in healthy volunteers: A randomized, two-way crossover trial.
    Kakuda TN; Leopold L; Nijs S; Vandevoorde A; Crauwels HM; Bertelsen KM; Stevens M; Witek J; van Delft Y; Tomaka F; Hoetelmans RM
    J Clin Pharmacol; 2014 May; 54(5):563-73. PubMed ID: 25975423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Hydroxyflavone and structural analogues differentially activate pregnane X receptor: Implication for inflammatory bowel disease.
    Lau AJ; Chang TK
    Pharmacol Res; 2015 Oct; 100():64-72. PubMed ID: 26238175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rilpivirine. First-line treatment of HIV infection: efavirenz is better documented.
    Prescrire Int; 2012 Nov; 21(132):262-5. PubMed ID: 23210255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors.
    Menéndez-Arias L; Betancor G; Matamoros T
    Antiviral Res; 2011 Nov; 92(2):139-49. PubMed ID: 21896288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic barrier to the development of resistance to rilpivirine and etravirine between HIV-1 subtypes CRF02_AG and B.
    Fofana DB; Soulie C; Maiga AI; Fourati S; Malet I; Wirden M; Tounkara A; Traore HA; Calvez V; Marcelin AG; Lambert-Niclot S
    J Antimicrob Chemother; 2013 Nov; 68(11):2515-20. PubMed ID: 23833185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zearalenone activates pregnane X receptor, constitutive androstane receptor and aryl hydrocarbon receptor and corresponding phase I target genes mRNA in primary cultures of human hepatocytes.
    Ayed-Boussema I; Pascussi JM; Maurel P; Bacha H; Hassen W
    Environ Toxicol Pharmacol; 2011 Jan; 31(1):79-87. PubMed ID: 21787672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of pregnane X receptor by carnosic acid, carnosol, ursolic acid, and rosmarinic acid.
    Seow CL; Lau AJ
    Pharmacol Res; 2017 Jun; 120():23-33. PubMed ID: 28288941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells.
    Hecht M; Erber S; Harrer T; Klinker H; Roth T; Parsch H; Fiebig N; Fietkau R; Distel LV
    PLoS One; 2015; 10(6):e0130277. PubMed ID: 26086472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etravirine and Rilpivirine Drug Resistance Among HIV-1 Subtype C Infected Children Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens in South India.
    Saravanan S; Kausalya B; Gomathi S; Sivamalar S; Pachamuthu B; Selvamuthu P; Pradeep A; Sunil S; Mothi SN; Smith DM; Kantor R
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):567-574. PubMed ID: 27869478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.